Nc1c(N(Cc2ccccc2)C(=O)CCc2ccccc2)c(=O)[nH]c(=O)n1Cc1ccccc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?